MAY-JUN 2018

MedEsthetics—business education for medical practitioners—provides the latest noninvasive cosmetic procedures, treatment trends, product and equipment reviews, legal issues and medical aesthetics industry news.

Issue link:

Contents of this Issue


Page 16 of 68

BEST PR ACTICES 14 MAY/JUNE 2018 | Med Esthetics © GETTY IMAGES VIRTUAL AESTHETICIAN ON DUTY Skincare manufacturers can provide a wealth of support to practices that carry retail products, from sampling programs to co-op ads and merchandising expertise. Now private label manufacturer, AMP Medical Products, has taken its customer service one step further with the introduction of its "Virtual Aesthetician" software. Customers can log on to the company's site ( Monday-Friday from 8:00 am-4:00 pm PT and video chat with a licensed esthetician. (Pre-scheduled weekend ap- pointments are also available.) The esthetician can answer questions about the company's products and ingredients, help customers with orders and assist in product design and development. PLIAGLIS ANESTHETIC NOW IN U.S. If you are not already wearing protective clothing, masks and eyewear during laser tattoo removal treatments, it is time to start. A new study published in Lasers in Surgery and Medicine on March 25 confi rmed that ink particles are ejected at speeds so high that they actually become embedded in glass slides held near the treatment site. Author Michael J. Murphy found dark material, presum- ably fragments of the tattoo ink, on and embedded within glass slides following Q-switched Nd:YAG laser treatment of tattoos. The particles ranged in size from 12 µm to 5mm and, while some were visible to the naked eye and easily washed off, others were visible only through photomicrographs. These fragments were seen 0.2mm to 1mm deep within the slides with evidence of fractured and melted glass. Ink Particles Ejected During Laser Tattoo Removal Aesthetic providers have a new tool available to increase patient comfort during minimally invasive cosmetic treatments. Pliaglis, a topical lidocaine and tetracaine (7%/7%) cream that, once applied to a patient's skin, dries to form a pliable layer that is peeled off once the skin is numbed, is now available in the United States. The FDA-approved topical anesthetic, which is distributed by Taro Pharmaceuticals, can be used on intact skin prior to superfi cial dermatological procedures, such as dermal fi ller injections, pulsed dye laser therapy, laser skin resurfacing and laser-assisted tattoo removal. For more information, visit

Articles in this issue

Links on this page

Archives of this issue

view archives of Medesthetics - MAY-JUN 2018